TITLE

T-20 SHOWS PROMISE

PUB. DATE
March 1999
SOURCE
AIDS Patient Care & STDs;Mar1999, Vol. 13 Issue 3, p200
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports on the results of the first multidose human trial of the antiretroviral T-20. Decrease in patients' viral load; Results of similar trials using triple-drug HAART and four-drug HAART.
ACCESSION #
2153745

 

Related Articles

  • AZT: An Old Drug with New Perspectives. D'Andrea, Gabriele; Brisdelli, Fabrizia; Bozzi, Argante // Current Clinical Pharmacology;Jan2008, Vol. 3 Issue 1, p20 

    The science of antiviral research was well advanced when HIV/AIDS appeared as a major new virus disease in the early 1980s. The first effective antiviral compound (AZT, azidothymidine, zidovudine) was already among the library of compounds screened and was promptly reported to be a specific...

  • Design and evaluation of stavudine transdermal patches using hydrophilic and hydrophobic polymers. Muzib, Y. Indira; Lavanya, T. // Journal of Pharmacy Research;2012, Vol. 5 Issue 2, p1176 

    The objective of the present research work was to develop suitable transdermal matrix patches of Stavudine, an anti-retroviral drug, and to investigate physico-chemical characteristics and in in vitro drug release of stavudine from the films of Eudragit RS100 and Hydroxy propyl methyl cellulose...

  • Antiviral Briefs.  // AIDS Patient Care & STDs;Jul2002, Vol. 16 Issue 7, p349 

    Reports on developments relevant to the antiviral drugs against AIDS and sexually-transmitted diseases. Condom use among HIV-infected men who are being treated with highly active antiretroviral therapy; Effectiveness of antivirals in older HIV-infected patients; Rhabdomyolysis that may be...

  • Randomized Study of Saquinavir with Ritonavir or Nelfinavir Together with Delavirdine, Adefovir... Gulick, Roy M.; Hu, X. Joan; Fiscus, Susan A.; Fletcher, Courtney V.; Haubrick, Richard; Cheng, Hailong; Acosta, Edward; Lagakos, Stephen W.; Swanstrom, Ronald; FischL, William; Pettinelli, Carla; Katzenstein, David // Journal of Infectious Diseases;11/1/2000, Vol. 182 Issue 5, p1375 

    Compares antiretroviral activity among salvage therapy regimens for HIV infections. Administration of saquinavir with ritonavir or nelfinavir together with delavirdine and/or adefovir; Monitoring of antiretroviral response between baseline and week 16; Percentage of patients who experienced...

  • Treatment-Mediated Changes in Human Immunodeficiency Virus (HIV) Type 1 RNA and CD4 Cell Counts... Lindsey, Jane C.; Hughes, Michael D.; McKinney, Ross E.; Cowles, Mary K.; England, Janet A.; Baker, Carol J.; Burchett, Sandra K.; Kline, Mark W.; Kovacs, Andrea; Moye, Jack // Journal of Infectious Diseases;11/1/2000, Vol. 182 Issue 5, p1385 

    Evaluates the predictive value of antiretroviral treatment-mediated changes in 3 markers of human immunodeficiency virus type 1 disease progression. HIV-1 RNA level; CD4 cell count; CD4 percentage; Weight growth failure; Cognitive decline; Survival of HIV-infected children; Differential age...

  • The Relationship between Virus Load Response to Highly Active Antiretroviral Therapy and Change... DeHovitz, Jack A.; Kovacs, Andrea; Feldman, Joseph G.; Anastos, Kathyrn; Young, Mary; Cohen, Mardge; Gange, Stephen J.; Melnick, Sandra; Greenblatt, Ruth M. // Journal of Infectious Diseases;11/1/2000, Vol. 182 Issue 5, p1527 

    Assesses the relationship between the pattern of virus load response to highly active antiretroviral therapy (HAART) and change in CD4 cell counts among HIV-1 infected women. Difference in trend in CD4 cell count by response to HAART; Observation of higher CD4 cell counts in patients who...

  • HIV-1 integrase polymorphisms are associated with prior antiretroviral drug exposure. van Hal, Sebastiaan J.; Herring, Belinda; Deris, Zaquan; Bin Wang; Saksena, Nitin K.; Dwyer, Dominic E. // Retrovirology;2009, Vol. 6, p1 

    In a recent summary of integrase sequences, primary integrase inhibitor mutations were rare. In a review of integrase inhibitor-naïve Australian HIV-1 sequences, primary mutations were not identified, although the accessory mutation G140S was detected. A link with previous antiretroviral...

  • Antiviral Briefs.  // AIDS Patient Care & STDs;Jul2001, Vol. 15 Issue 7, p399 

    Reports on various developments in antiviral research as of July 2001. Filing with the United States Food and Drug Administration by Gilead Sciences for its antiviral agent tenovir; Impact of the combination therapy of AZT and 3TC on the transmission rate of HIV between mother and infant;...

  • Selection of Drug-Resistant Variants in the Female Genital Tract of... Si-Mohamed, Ali; Kazatchkine, Michel D.; Heard, Isabelle; Goujon, Christophe; Prazuck, Thierry; Aymard, Guy; Cessot, Gilles; Yu-Hung Kuo; Bernard, Marie-Charlotte; Diquet, Bertrand; Malkin, Jean-Elie; Gutmann, Laurent; Belec, Laurent // Journal of Infectious Diseases;7/1/2000, Vol. 182 Issue 1, p112 

    Investigates the presence of free HIV-1 RNA, cell-associated proviral DNA and HIV-1 variants with drug-resistance mutations and the local concentration of antiviral drugs in the genital secretions of women receiving antiretroviral therapy. Demographic characteristics and biological findings;...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics